Statistics about Health, Pharma & Medtech in United States
Statistics
- Tharimmune operating profit 2020-2023
- Tharimmune total assets 2020-2023
- Tharimmune liabilities 2020-2023
- Celcuity liabilities 2019-2023
- Celularity Inc total assets 2019-2023
- Celcuity operating profit 2019-2023
- Nexien Biopharma, Inc. total assets 2019-2023
- Celularity Inc operating profit 2019-2023
- Celularity Inc total equity 2019-2023
- Celcuity net cash 2019-2023
- Nanoviricides total assets 2020-2024
- Nanomix Corp total assets 2018-2022
- Tevogen Bio Holdings Inc. total assets 2021-2023
- Celularity Inc net income 2020-2023
- Celularity Inc revenue 2020-2023
- Nektar Therapeutics total assets 2019-2023
- Celcuity total equity 2019-2023
- Chromadex Corp. net cash 2019-2023
- Chromadex Corp. total equity 2019-2023
- Chromadex Corp. total assets 2019-2023
- Chromadex Corp. revenue 2019-2023
- Tharimmune total equity 2019-2023
- Tevogen Bio Holdings Inc. liabilities 2021-2023
- Cingulate Inc. net cash 2020-2023
- Tevogen Bio Holdings Inc. net cash 2022-2023
- Cingulate Inc. liabilities 2020-2023
- Cingulate Inc. operating profit 2020-2023
- Assembly Biosciences, Inc. total assets 2019-2023
- Cellectar Biosciences, Inc. total equity 2019-2023
- Aeon Global Health Corp. total equity 2015-2019
- Acasti Pharma Inc. operating profit 2019-2023
- Akero Therapeutics net income 2019-2023
- Acumen Pharmaceuticals liabilities 2020-2023
- Acumen Pharmaceuticals operating profit 2020-2023
- Akero Therapeutics operating profit 2019-2023
- Natures Sunshine Products Inc liabilities 2019-2023
- Navidea Biopharmaceuticals, Inc. liabilities 2018-2022
- Acasti Pharma Inc. liabilities 2019-2023
- Acasti Pharma Inc. total equity 2019-2023
- Acasti Pharma Inc. total assets 2019-2023
- Cv Sciences, Inc. operating profit 2019-2023
- Acasti Pharma Inc. net cash 2019-2023
- Cv Sciences, Inc. liabilities 2019-2023
- Cv Sciences, Inc. revenue 2019-2023
- Twinlab Consolidated Holdings revenue 2019-2023
- Acumen Pharmaceuticals net cash 2020-2023
- Eliem Therapeutics liabilities 2020-2023
- Eliem Therapeutics operating profit 2020-2023
- Cv Sciences, Inc. gross profit 2019-2023
- Cv Sciences, Inc. net income 2012-2015
- Akero Therapeutics total equity 2019-2023
- Acasti Pharma Inc. revenue 2020-2021
- Akero Therapeutics total assets 2019-2023
- Eliem Therapeutics net cash 2020-2023
- Molecular Templates, Inc. liabilities 2019-2023
- Eliem Therapeutics total assets 2020-2023
- Eliem Therapeutics net income 2020-2023
- Akero Therapeutics liabilities 2019-2023
- Musclepharm liabilities 2017-2021
- Akero Therapeutics net cash 2019-2023
- Cv Sciences, Inc. net cash 2019-2023
- Nascent Biotech total assets 2019-2023
- Century Therapeutics total assets 2020-2023
- Akebia Therapeutics operating profit 2019-2023
- Musclepharm net cash 2011-2021
- Neogen liabilities 2020-2024
- Accustem Sciences Inc. total equity 2020-2023
- Akebia Therapeutics revenue 2019-2023
- Accustem Sciences Inc. total assets 2021-2023
- Accustem Sciences Inc. net cash 2022-2023
- Neurocrine Biosciences liabilities 2019-2023
- Accustem Sciences Inc. liabilities 2021-2023
- Accustem Sciences Inc. operating profit 2021-2023
- Ainos total equity 2019-2023
- Ainos total assets 2019-2023
- Cervomed revenue 2011-2023
- Akebia Therapeutics liabilities 2019-2023
- Cervomed net income 2012-2014
- Cervomed gross profit 2010-2013
- Cervomed total assets 2019-2023
- Cervomed total equity 2019-2023
- Cervomed operating profit 2019-2023
- Cervomed liabilities 2019-2023
- Neubase Therapeutics total assets 2018-2022
- Cv Sciences, Inc. total equity 2019-2023
- Acumen Pharmaceuticals total assets 2020-2023
- Akebia Therapeutics net cash 2019-2023
- Thorne Healthtech revenue 2020-2022
- Akebia Therapeutics total assets 2019-2023
- Cv Sciences, Inc. total assets 2019-2023
- Natural Alternatives liabilities 2020-2024
- Cervomed net cash 2019-2023
- Acumen Pharmaceuticals total equity 2019-2023
- Akebia Therapeutics total equity 2019-2023
- Trex Wind-Down, Inc. revenue 2017-2022
- Century Therapeutics revenue 2022-2023
- Molecular Templates, Inc. net cash 2019-2023
- Cardiff Oncology net cash 2019-2023
- Neogen net income 2019-2023
- Aeon Global Health Corp. liabilities 2015-2019